ADVANCED CELLULAR THERAPIES TO RESTORE IMMUNE BALANCE
We genetically modify thymus-derived regulatory T cells (thyTregs) using chimeric antigen receptor (CAR) technology.
Thanks to these antigen-specific CAR-thyTregs, we aim to develop a disease-specific therapy for each autoimmune disease or prevent rejection in different types of transplantation
CUTTING-EDGE RESEARCH ON EXTRACELLULAR VESICLES
Cells rely on different communication pathways to carry out their many functions
Extracellular vesicles produced by thyTregs have been studied and characterized based on their size, concentration, and phenotype or morphology using several techniques implemented in the laboratory
IMMUNE RESPONSE TO COVID-19 AND THE EFFECT OF VACCINES
Study of immune cell populations and biochemical markers that may help predict the impact of COVID-19 in different cohorts.
Study of anti-SARS-CoV-2 humoral and cellular memory in convalescent patients.
Study of the cellular and humoral immune response following administration of mRNA vaccines against SARS-CoV-2.
Identification of clinical and genetic profiles associated with the response to SARS-CoV-2.
